SuperworthAclaris Therapeutics market cap ACRS
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $552M
- Highest close in our data
- $1.5B
- Apr 2021
Aclaris Therapeutics is worth $552M at the close on Oct 23, 2026, at $3.75 a share.
That is up 137% over the last year and down 48% over five years.
Its highest close in our data was $1.5B in Apr 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $552M | $283.9M | $943.5M | +68% |
| 2025 | $328.3M | $123M | $352.1M | +68% |
| 2024 | $195M | $65.5M | $290.7M | +162% |
| 2023 | $74.4M | $59.4M | $1.2B | −93% |
| 2022 | $1.1B | $596.4M | $1.2B | +18% |
| 2021 | $890.2M | $252.4M | $1.5B | +221% |
| 2020 | $277.7M | $37.4M | $326.6M | +249% |
| 2019 | $79.5M | $36.1M | $312.3M | −73% |
| 2018 | $299.2M | $285.7M | $770.9M | −61% |
| 2017 | $760.4M | $554.5M | $846.6M | +31% |
| 2016 | $581.7M | $297.7M | $669.8M | +7% |
| 2015 | $543M | $425.9M | $584.4M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Aclaris Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| ACRSAclaris Therapeutics | $552M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| ARVNArvinas | $477.3M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $597.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Aclaris Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.